Back to search

Boston University

Overview and comparative analysis of the efficacy and safety of current and emerging treatment regimens for diffuse large B-cell lymphoma: implications for future patient outcomes

Abstract

dc:description.abstract

Diffuse large B-cell lymphoma (DLBCL) makes up 30% of non-Hodgkin’s lymphoma (NHL) cases and is widely considered the most common of the NHL subtypes. Most patients are responsive to the 1st-line therapy, R-CHOP; however, 40-50% of cases relapse, are refractory, or completely unresponsive. The available 2nd and 3rd-line therapies include CAR T-cell therapy, salvage ASCT + HDT, immunotherapies, and bispecific monoclonal antibodies, although some 2nd and 3rd-line therapies have modest efficacies, ORR, and CR rates. Moreover, therapies such as CAR T-cell and salvage ASCT + HDT are associated with high-grade AEs and CRS symptoms. In the battle to cure DLBCL, it is imperative to develop treatment options that provide durability while not affecting quality of life. Thus, more targeted therapies such as ADCs, immune checkpoint inhibitors, and novel therapeutic combinations may be key for the future of DLBCL. This thesis provides an overview of the etiology and pathogenesis of DLBCL and comments on the current treatments, their limitations, and the emerging therapies that are promising for the future of DLBCL treatment and outcomes.

Degree

thesis:*
Name thesis:degree_name
Master of Science
Level thesis:degree_level
masters
Discipline thesis:degree_discipline
Medical Sciences
Grantor
Boston University
Year dc:date.issued
2025

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Reid, Zuri N.
Advisors dc:contributor.advisor
  • Walsh, Carol T.
  • Sloan, Mark

Subjects

dc:subject × 5

Rights

dc:rights
Statement dc:rights
  • Attribution-NonCommercial-NoDerivatives 4.0 International
Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/2144/52420

Chain of custody

source
Harvested from
Boston University
Base URL
open.bu.edu/oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Reid, Zuri N.. Overview and comparative analysis of the efficacy and safety of current and emerging treatment regimens for diffuse large B-cell lymphoma: implications for future patient outcomes. masters thesis, Boston University, 2025. https://hdl.handle.net/2144/52420